This website is intended for healthcare professionals only.
Newsletter
MENU
MENU
News
Covid-19
Clinical
Allergy
Emergency and critical care
Gastroenterology
Respiratory
Cardiovascular
Oncology/Haematology
Radiology and Imaging
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
MENU
MENU
News
Covid-19
Clinical
Allergy
Emergency and critical care
Gastroenterology
Respiratory
Cardiovascular
Oncology/Haematology
Radiology and Imaging
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
Latest news
Sacubitril-valsartan provides no mortality benefit compared with ramipril in acute MI with reduced ejection fraction
Ciclesonide no better than placebo for COVID-19 symptom resolution
More news
Byannli approved by EMA for twice-yearly dosing in schizophrenia
Eye protection appears to reduce COVID-19 infection in healthcare workers
Risankizumab approved by EMA for active psoriatic arthritis
Atezolizumab and nivolumab prolong overall survival compared with docetaxel in NSCLC
Cancer diagnoses in young people fell but ICU admissions increased during first wave of pandemic
HRT use increases risk of disease recurrence in breast cancer survivors
Breast milk found to contain neutralising COVID-19 antibodies
Delayed transfer of care predictive model 70% accurate
High discrepancy rate in interpretation of advanced scans among specialist radiologists
Page 1 of 364
1
2
3
4
5
...
10
20
30
...
»
Last »
Popular articles
Haematological cancer patients at increased risk of severe breakthrough COVID-19 infections
22 November, 2021
Byannli approved by EMA for twice-yearly dosing in schizophrenia
24 November, 2021
Strong opiates equivalent to paracetamol and codeine for post-orthopaedic surgery pain
23 November, 2021
Eye protection appears to reduce COVID-19 infection in healthcare workers
23 November, 2021
Risankizumab approved by EMA for active psoriatic arthritis
22 November, 2021
